{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:37Z","timestamp":1787758237019,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Extended-spectrum beta-lactamases (ESBL) are the most widespread of the new beta-lactamases and are a significant threat to patient care in the hospital and the community. Aim: The study assessed the prevalence, antibiotic susceptibility profile, and major ESBL encoding genes among\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      isolated from clinical specimens of patients in the National Hospital, Abuja (NHA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      isolated from diverse clinical specimens obtained from clinically proven cases of infection managed at the NHA were included in the study. The antimicrobial susceptibility was performed by the Kirby\u2013Bauer method and E-test was used to confirm the ESBL phenotype. Multiplex polymerase chain reaction (PCR) was used to detect the genes mediating ESBL production.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Meropenem, fosfomycin, and tigecycline demonstrated excellent activities against all isolates: of the 400 isolates, 392 (98%), 386 (96.5%), and 362 (90.5%) were susceptible, respectively. Similarly, 358 (89.5%) were susceptible to amikacin, 323 (80.3%) nitrofurantoin, 281 (70.3%) ceftazidime, and 279 (69.8%) cefotaxime. A total of 271 (67.8%), 219 (54.8%), and 208 (52.0%) were resistant to amoxicillin\u2013clavulanate, ciprofloxacillin, and gentamicin, respectively. However, all the isolates were resistant to ampicillin. There was a significantly higher proportion of multidrug resistance among ESBL-producing isolates compared to non-ESBL-producing isolates (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001). Of the 121 phenotypically detected ESBL isolates, 119 (98.3%) harbored genes mediating the production of Cefotaximase\u2013 Munich (CTX-M), Temoniera (TEM) or Sulfhydryl Variable (SHV) enzymes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The prevalence of ESBLs among\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      was relatively high, at 30.2%. About 81% of all blood isolates were ESBL-producers.\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>CTX-M<\/jats:sub>\n                      is the predominant type of ESBL gene among\n                      <jats:italic toggle=\"yes\">E. coli.<\/jats:italic>\n                      A high proportion of the ESBL-producing isolates expressed a combination of two or three genes together.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_1390_21","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T13:09:27Z","timestamp":1660655367000},"page":"1216-1220","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Antibiotic Susceptibility Profiles and Detection of Genes Mediating Extended-Spectrum \u03b2-Lactamase (Esbl) Production in Escherichia Coli Isolates from National Hospital, Abuja"],"prefix":"10.4103","volume":"25","author":[{"given":"S O","family":"Enyinnaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C","family":"Iregbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Y","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V O","family":"Rotimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240907","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new \u03b2-Lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-3-20240907","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.coph.2007.08.003","article-title":"The continuing challenge of ESBLs","volume":"7","author":"Perez","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"R3-3-20240907","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of beta-lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-3-20240907","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0377-4929.40428","article-title":"Prevalence of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolates in a tertiary care hospital","volume":"51","author":"Agrawal","year":"2008","journal-title":"Indian J Pathol Microbiol"},{"key":"R5-3-20240907","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: An emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R6-3-20240907","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","article-title":"Extended-spectrum beta-lactamase-producing organisms","volume":"73","author":"Falagas","year":"2009","journal-title":"J Hosp Infect"},{"key":"R7-3-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: A pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R8-3-20240907","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13756-016-0114-7","article-title":"Infections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae: Clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, Senegal","volume":"5","author":"Ndir","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"R9-3-20240907","first-page":"1615","article-title":"Prevalence of multidrug resistant Enterobacteriaceae and extended spectrum beta lactamase producing Escherichia coli in urinary tract infection","volume":"4","author":"Thakur","year":"2013","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"R10-3-20240907","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: Changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R11-3-20240907","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-0711-11-19","article-title":"First description of Escherichia coli producing CTX-M-15- extended spectrum beta lactamase (ESBL) in out-patients from South Eastern Nigeria","volume":"11","author":"Iroha","year":"2012","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R12-3-20240907","first-page":"486","article-title":"Therapeutic drug monitoring of amikacin in preterm and term infants","volume":"50","author":"Siddiqi","year":"2009","journal-title":"Singapore Med J"},{"key":"R16-3-20240907","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12941-015-0079-z","article-title":"Simple multiplex PCR assays to detect common pathogens and associated genes encoding for acquired extended spectrum betalactamases (ESBL) or carbapenemases from surgical site specimens in Vietnam","volume":"14","author":"Trung","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R17-3-20240907","first-page":"53","article-title":"Extended-Spectrum \u00df-Lactamases in isolates of Klebsiella spp and Escherichia coli from Lagos, Nigeria","volume":"2","author":"Aibinu","year":"2003","journal-title":"Niger J Health Biomed Sci"},{"key":"R18-3-20240907","first-page":"141","article-title":"Detection of extended spectrum beta-lactamases in gram negative bacilli from clinical specimens in a teaching hospital in South Eastern Nigeria","volume":"51","author":"Akujobi","year":"2010","journal-title":"Niger Med J"},{"key":"R19-3-20240907","first-page":"20","article-title":"The prevalence of extended spectrum beta-lactamases (ESBLs) among Escherichia coli and Klebsiella species urinary isolates from Abia state university teaching hospital (ABSUTH) Aba, Abia State, Nigeria","volume":"2","author":"Nwosu","year":"2014","journal-title":"Int J Microbiol Mycol"},{"key":"R20-3-20240907","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3923\/crb.2010.77.83","article-title":"Detection of plasmid borne extended spectrum beta lactamase enzymes from blood and urine isolates of gram negative bacteria from a Univerisity Teaching Hospital in Nigeria","volume":"3","author":"Iroha","year":"2010","journal-title":"Curr Res Bacteriol"},{"key":"R21-3-20240907","first-page":"140","article-title":"Extended-spectrum beta-lactamase production among clinical isolates of Escherichia coli","volume":"3","author":"Okesola","year":"2012","journal-title":"Int Res J Microbiol"},{"key":"R22-3-20240907","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4314\/tjpr.v14i7.21","article-title":"Antibiotic susceptibility pattern of extended spectrum betalactamase (ESBL) producers and other bacterial pathogens in Kano, Nigeria","volume":"14","author":"Emmanuel","year":"2015","journal-title":"Trop J Pharmaceut Res"},{"key":"R23-3-20240907","first-page":"69","article-title":"Incidence of multi-drug resistance (MDR) organisms in Abeokuta, Southwestern Nigeria","volume":"3","author":"Okonko","year":"2009","journal-title":"Glob J Pharmacol"},{"key":"R24-3-20240907","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.48.10.3758-3764.2004","article-title":"Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada","volume":"48","author":"Boyd","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-3-20240907","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000321242","article-title":"Sequence analysis of blaCTX-M genes carried by clinically significant Escherichia coli isolates in Kuwait hospitals","volume":"20","author":"Al Hashem","year":"2011","journal-title":"Med Princ Pract"},{"key":"R26-3-20240907","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1469-0691.2007.01855.x","article-title":"Prevalence and clonality of extended-spectrum beta-lactamases in Asia","volume":"14","author":"Hawkey","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"R27-3-20240907","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/1471-2334-13-466","article-title":"Predominance of Klebsiella pneumoniae ST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania","volume":"13","author":"Mshana","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R28-3-20240907","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12879-015-1005-x","article-title":"Sequence analysis of genes mediating extended-spectrum beta-lactamase (ESBL) production in isolates of Enterobacteriaceae in a Lagos Teaching Hospital, Nigeria","volume":"15","author":"Raji","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R29-3-20240907","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1111\/j.1469-0691.2011.03730.x","article-title":"Sequence Type ST131 and ST10 Complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria","volume":"18","author":"Aibinu","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R30-3-20240907","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/0974-777X.68531","article-title":"Extended-spectrum \u03b2-lactamases in gram negative bacteria","volume":"2","author":"Rawat","year":"2010","journal-title":"J Glob Infect Dis"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1390_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:10:10Z","timestamp":1787757010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1390_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_1390_21","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}